Zurcher Kantonalbank (Zurich Cantonalbank) Adverum Biotechnologies, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$1.74 - $2.4 $13,304 - $18,350
-7,646 Closed
0 $0
Q2 2020

Jul 28, 2020
SELL
$8.53 - $25.64 $17,836 - $53,613
-2,091 Reduced 21.47%
7,646 $160,000
Q1 2020

May 06, 2020
BUY
$7.98 - $16.32 $13,318 - $27,238
1,669 Added 20.69%
9,737 $95,000
Q4 2019

Jan 21, 2020
BUY
$5.12 - $12.22 $41,308 - $98,590
8,068 New
8,068 $93,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email